<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.04207.007</object-id><label>Table 1.</label><caption><p>Term enrichment among FOXL2 targets in cultured murine primary cells and FOXL2 targets shared with in vivo analysis</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04207.007">http://dx.doi.org/10.7554/eLife.04207.007</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th>ID</th><th>Term</th><th>Count</th><th>Bonferroni</th><th>p-Value</th><th>Genes</th></tr></thead><tbody><tr><td colspan="6">GO TERM ENRICHMENT of FOXL2 target genes</td></tr><tr><td>&#8195;GO:0007155</td><td>cell adhesion</td><td>34</td><td>6.10<sup>&#8722;6</sup></td><td>3.10<sup>&#8722;9</sup></td><td><italic>NRP2, CDK5R1, CLSTN2, MYBPC3, LMO7, CLDN11, SOX9, CD24A, CNTNAP5A, TGFB2, WISP2, WISP1, PVRL1, ADAM2, MSLN, ACAN, COL6A2, PSTPIP1, COL6A1, ITGA1, ITGA2, PCDH8, PCDH7, EMILIN2, MCAM, GPR98, PCDH18, AMIGO2, ITGA9, OMD, FREM2, ITGA7, VCAN, BMPR1B</italic></td></tr><tr><td>&#8195;GO:0022610</td><td>biological adhesion</td><td>34</td><td>6.10<sup>&#8722;6</sup></td><td>3.10<sup>&#8722;9</sup></td><td><italic>NRP2, CDK5R1, CLSTN2, MYBPC3, LMO7, CLDN11, SOX9, CD24A, CNTNAP5A, TGFB2, WISP2, WISP1, PVRL1, ADAM2, MSLN, ACAN, COL6A2, PSTPIP1, COL6A1, ITGA1, ITGA2, PCDH8, PCDH7, EMILIN2, MCAM, GPR98, PCDH18, AMIGO2, ITGA9, OMD, FREM2, ITGA7, VCAN, BMPR1B</italic></td></tr><tr><td>&#8195;GO:0010817</td><td>regulation of hormone levels</td><td>16</td><td>2.10<sup>&#8722;5</sup></td><td>1.10<sup>&#8722;8</sup></td><td><italic>HSD17B1, EXOC3L, ADH7, VGF, IRS1, ALDH1A2, ACE, RDH10, DIO2, AKR1C18, CHST8, HSD11B2, BMPR1B, PCSK5, SMPD3, CYP19A1</italic></td></tr><tr><td>&#8195;GO:0042127</td><td>regulation of cell proliferation</td><td>29</td><td>1.10<sup>&#8722;3</sup></td><td>7.10<sup>&#8722;7</sup></td><td><italic>FGFR2, FGF18, PTGS2, PPARG, BTC, FOXO1, SOX9, CD24A, ADORA1, TGFB2, ALDH1A2, BDNF, SPRY1, S1PR1, CDKN2B, HEY2, GRPR, ADAM33, PTGER2, BMP2, ICOSL, IL7, EFNB1, ESR2, IRS1, EREG, EPGN, PLAU, BMPR1A</italic></td></tr><tr><td>&#8195;GO:0042445</td><td>hormone metabolic process</td><td>12</td><td>1.10<sup>&#8722;3</sup></td><td>8.10<sup>&#8722;7</sup></td><td><italic>ALDH1A2, ACE, RDH10, DIO2, AKR1C18, HSD17B1, CHST8, HSD11B2, ADH7, BMPR1B, PCSK5, CYP19A1</italic></td></tr><tr><td>&#8195;GO:0040007</td><td>growth</td><td>16</td><td>5.10<sup>&#8722;3</sup></td><td>3.10<sup>&#8722;6</sup></td><td><italic>FGFR2, BMP2, PTGS2, GJA1, MREG, SOX9, TIMP3, TGFB2, RDH10, EREG, MFSD7B, ETNK2, BMPR1B, BMPR1A, CYP19A1, ADD1</italic></td></tr><tr><td>&#8195;GO:0016337</td><td>cell&#8211;cell adhesion</td><td>17</td><td>1.10<sup>&#8722;2</sup></td><td>8.10<sup>&#8722;6</sup></td><td><italic>CDK5R1, CLSTN2, LMO7, PCDH8, CLDN11, PCDH7, MCAM, SOX9, CD24A, GPR98, TGFB2, PCDH18, AMIGO2, PVRL1, FREM2, ACAN, BMPR1B</italic></td></tr><tr><td>&#8195;GO:0001568</td><td>blood vessel development</td><td>17</td><td>2.10<sup>&#8722;2</sup></td><td>1.10<sup>&#8722;5</sup></td><td><italic>FGFR2, FGF18, TBX20, FOXO1, GJA1, CXCL12, TGFB2, ALDH1A2, S1PR1, EREG, EPGN, ITGA7, HEY2, ROBO4, ANGPT1, COL1A1, ANGPT2</italic></td></tr><tr><td>&#8195;GO:0048589</td><td>developmental growth</td><td>11</td><td>3.10<sup>&#8722;2</sup></td><td>2.10<sup>&#8722;5</sup></td><td><italic>FGFR2, RDH10, EREG, PTGS2, GJA1, BMPR1B, MREG, SOX9, TIMP3, BMPR1A, CYP19A1</italic></td></tr><tr><td>&#8195;GO:0001944</td><td>vasculature development</td><td>17</td><td>3.10<sup>&#8722;2</sup></td><td>2.10<sup>&#8722;5</sup></td><td><italic>FGFR2, FGF18, TBX20, FOXO1, GJA1, CXCL12, TGFB2, ALDH1A2, S1PR1, EREG, EPGN, ITGA7, HEY2, ROBO4, ANGPT1, COL1A1, ANGPT2</italic></td></tr><tr><td>&#8195;GO:0048608</td><td>reproductive structure development</td><td>12</td><td>5.10<sup>&#8722;2</sup></td><td>3.10<sup>&#8722;5</sup></td><td><italic>FGFR2, DHH, RDH10, EREG, FST, ADAMTS1, ESR2, BMPR1B, VGF, SOX9, LFNG, CYP19A1</italic></td></tr><tr><td colspan="6">PANTHER CLASSIFICATION of FOXL2 target genes</td></tr><tr><td>&#8195;BP00274</td><td>Cell communication</td><td>31</td><td>7.10<sup>&#8722;4</sup></td><td>6.10<sup>&#8722;6</sup></td><td><italic>CXCL5, CLSTN2, PPARG, BTC, FOXO1, CNTNAP5A, ASGR1, ASGR2, WISP2, BDNF, PVRL1, ADAM2, ANGPT1, HTR1D, ANGPT2, ODZ4, SLC8A1, IL7, EFEMP2, PCDH8, ESR2, PCDH7, GPR98, ARHGAP26, PCDH18, OMD, FREM2, EPGN, VCAN, PLAU, IGFBP4</italic></td></tr><tr><td>&#8195;BP00102</td><td>Signal transduction</td><td>70</td><td>2.10<sup>&#8722;3</sup></td><td>1.10<sup>&#8722;5</sup></td><td><italic>NRP2, NDST4, CLSTN2, BTC, PPARG, GJA1, FOXO1, CNTNAP5A, ASGR1, ASGR2, BDNF, WISP2, S1PR1, GAB2, CXCR7, ADAM2, PDE4B, STARD8, ANGPT1, CHST15, HTR1D, RAMP1, ANGPT2, CCRL1, ODZ4, PTGER2, ARHGEF7, PCDH8, ESR2, PCDH7, IRS1, GPR98, ARHGAP26, AMIGO2, PLCE1, EREG, LYST, VCAN, RASD1, CAMK1D, FGFR2, IL1R1, CXCL5, SAV1, HS3ST1, PVRL1, GRPR, PCSK5, OLFM1, PIK3R1, SLC8A1, IL7, RASEF, EFEMP2, SPSB4, VMN2R11, SHANK2, RCAN2, PCDH18, DUSP5, EPHA4, OMD, RPS6KA1, RGS2, EPGN, FREM2, RGS4, BMPR1B, PLAU, IGFBP4</italic></td></tr><tr><td colspan="6">GO TERM ENRICHMENT of the &#8216;in vivo&#8217; FOXL2 target (71 genes at the intersection between our data and <xref ref-type="bibr" rid="bib27">Ulenhaut's 2009</xref>)</td></tr><tr><td>&#8195;GO:0010817</td><td>regulation of hormone levels</td><td>7</td><td>1.10<sup>&#8722;2</sup></td><td>2.10<sup>&#8722;5</sup></td><td><italic>HSD17B1, CHST8, HSD11B2, EXOC3L, BMPR1B, PCSK5, CYP19A1</italic></td></tr><tr><td>&#8195;GO:0042445</td><td>hormone metabolic process</td><td>6</td><td>3.10<sup>&#8722;2</sup></td><td>4.10<sup>&#8722;5</sup></td><td><italic>HSD17B1, CHST8, HSD11B2, BMPR1B, PCSK5, CYP19A1</italic></td></tr></tbody></table><table-wrap-foot><fn><p>Gene lists (FOXL2 targets or FOXL2 targets shared with <xref ref-type="bibr" rid="bib27">Uhlenhaut et al., 2009</xref>) were analysed using the DAVID server (<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/"><bold>david</bold>.abcc.ncifcrf.gov/</ext-link>) to find significantly enriched terms among the GO Biological Process and Panther Biological Process databases. Only terms enriched with a Bonferroni p-value &lt;0.05 were retained.</p></fn></table-wrap-foot></table-wrap>